Jiataile (sacituzumab tirumotecan) - Merck (MSD)
Cotelet (tagitanlimab) - Harbour BioMed
SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies (clinicaltrials.gov) - Aug 1, 2026 - P2 | N=80 | Not yet recruiting | Sponsor: Peking Union Medical College Hospital 
dMMR • MSI-H • New P2 trial • Endometrial Cancer • Gynecologic Cancers • Microsatellite Instability • Oncology • Ovarian Cancer • MLH1 • MSH2 • MSH6 • MSI
http://clinicaltrials.gov/ct2/show/NCT07738757
 
Aug 1, 2026
 
Prev Next